KR20010101443A - 신규 뎁시펩티드 화합물 - Google Patents
신규 뎁시펩티드 화합물 Download PDFInfo
- Publication number
- KR20010101443A KR20010101443A KR1020017008693A KR20017008693A KR20010101443A KR 20010101443 A KR20010101443 A KR 20010101443A KR 1020017008693 A KR1020017008693 A KR 1020017008693A KR 20017008693 A KR20017008693 A KR 20017008693A KR 20010101443 A KR20010101443 A KR 20010101443A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- voice
- culture
- positivity
- medium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Q71576주의 생리적 성질 (1) | |
질산염의 환원 | 음성 |
탈질소 반응 | 음성 |
MR 테스트 | 음성 |
VP 테스트 | 음성 |
인돌의 생성 | 음성 |
황화수소의 생성 | 음성 |
전분의 가수분해 | 음성 |
시트르산의 이용 | 양성 |
질산염의 이용 | 양성 |
암모늄염의 이용 | 양성 |
수용성 형광 색소의 생성 | 양성 |
우레아제 | 음성 |
옥시다제 | 양성 |
카탈라제 | 양성 |
생육 온도 범위 | 3 내지 32℃ |
최적 생육 온도 | 10 내지 24℃ |
생육 pH 범위 | pH 5 내지 9 |
최적 생육 pH | pH 6 내지 8 |
혐기 조건에서의 생육 | 음성 |
OF 테스트 | 산화형 |
아르기닌 분해반응 | 양성 |
3% NaCl 첨가 육즙 배지에서의 생육 | 양성 |
Q71576주의 생리적 성질 (2) | |
당으로부터 산의 생산 | |
L-아라비노스 | 양성 |
D-크실로스 | 양성 |
D-글루코스 | 양성 |
D-만노스 | 양성 |
D-프럭토스 | 음성 |
슈크로스 | 음성 |
이노시톨 | 음성 |
D-만니톨 | 음성 |
D-갈락토스 | 음성 |
말토스 | 음성 |
트레할로스 | 음성 |
락토스 | 음성 |
D-소르비톨 | 음성 |
글리세린 | 음성 |
전분 | 음성 |
Q71576주의 생리적 성질 (3) | |
당의 자화성 | |
L-아라비노스 | 음성 |
D-크실로스 | 음성 |
D-글루코스 | 양성 |
D-만노스 | 양성 |
D-프럭토스 | 양성 |
슈크로스 | 음성 |
이노시톨 | 양성 |
람노스 | 음성 |
라피노스 | 음성 |
D-만니톨 | 양성 |
D-갈락토스 | 양성 |
말토스 | 음성 |
트레할로스 | 양성 |
락토스 | 음성 |
소르비톨 | 양성 |
살리신 | 음성 |
멜리비오스 | 음성 |
글리세린 | 양성 |
전분 | 음성 |
크산틴 | 양성 |
키틴 | 음성 |
Claims (3)
- 하기 화학식 1로 표시되는 뎁시펩티드 화합물 또는 그의 제약학적으로 허용되는 염.<화학식 1>식 중에서, R은 이소프로필기, sec-부틸기 또는 이소부틸기를 의미한다.
- 제1항에 기재된 뎁시펩티드 화합물 또는 그의 제약학적으로 허용되는 염을 유효 성분으로 함유하는 의약 조성물.
- 제2항에 있어서, 항종양제인 의약 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-1999-00007040 | 1999-01-13 | ||
JP704099 | 1999-01-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010101443A true KR20010101443A (ko) | 2001-11-14 |
KR100611265B1 KR100611265B1 (ko) | 2006-08-10 |
Family
ID=11654946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017008693A KR100611265B1 (ko) | 1999-01-13 | 2000-01-12 | 신규 뎁시펩티드 화합물 |
Country Status (13)
Country | Link |
---|---|
US (2) | US6670326B1 (ko) |
EP (1) | EP1142905B1 (ko) |
JP (1) | JP3554707B2 (ko) |
KR (1) | KR100611265B1 (ko) |
CN (1) | CN1173990C (ko) |
AT (1) | ATE331730T1 (ko) |
AU (1) | AU2002700A (ko) |
CA (1) | CA2356845C (ko) |
DE (1) | DE60029084T2 (ko) |
DK (1) | DK1142905T3 (ko) |
ES (1) | ES2265906T3 (ko) |
PT (1) | PT1142905E (ko) |
WO (1) | WO2000042062A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1246839B1 (en) * | 1999-12-08 | 2004-06-16 | Xcyte Therapies, Inc. | Depsipeptide and congeners thereof for use as immunosuppressants |
EP1548026A4 (en) * | 2002-08-30 | 2006-03-22 | Yamanouchi Pharma Co Ltd | NEW DEPSIPEPTID CONNECTION |
EP1920779A4 (en) * | 2005-08-12 | 2010-03-10 | Astellas Pharma Inc | YW753 PREPARATION STABILIZATION TECHNIQUE |
US7943568B2 (en) * | 2005-09-30 | 2011-05-17 | The Ohio State University Research Foundation | Antitumor agents |
GB0623357D0 (en) * | 2006-11-22 | 2007-01-03 | Karus Therapeutics Ltd | Chemical compounds |
AU2007323215B2 (en) * | 2006-11-22 | 2012-07-19 | Karus Therapeutics Limited | Depsipeptides and their therapeutic use |
GB0623388D0 (en) | 2006-11-23 | 2007-01-03 | Univ Southampton | Chemical compounds |
GB0715750D0 (en) * | 2007-08-13 | 2007-09-19 | Karus Therapeutics Ltd | Chemical compounds |
US20150352076A1 (en) | 2013-01-25 | 2015-12-10 | Toshiyuku SAKAI | Molecularly targeted combination drug for tumor treatment and prevention |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61101501A (ja) | 1984-10-24 | 1986-05-20 | Yamanouchi Pharmaceut Co Ltd | 制癌作用を有する多糖及びその製法 |
GB8817743D0 (en) * | 1988-07-26 | 1988-09-01 | Fujisawa Pharmaceutical Co | Fr901228 substance & preparation thereof |
US5681813A (en) * | 1994-04-06 | 1997-10-28 | Pharma Mar, S.A. | Thiodepsipeptide isolated from a marine actinomycete |
-
2000
- 2000-01-12 AU AU20027/00A patent/AU2002700A/en not_active Abandoned
- 2000-01-12 PT PT00900351T patent/PT1142905E/pt unknown
- 2000-01-12 DE DE60029084T patent/DE60029084T2/de not_active Expired - Lifetime
- 2000-01-12 EP EP00900351A patent/EP1142905B1/en not_active Expired - Lifetime
- 2000-01-12 CA CA2356845A patent/CA2356845C/en not_active Expired - Lifetime
- 2000-01-12 US US09/889,303 patent/US6670326B1/en not_active Expired - Lifetime
- 2000-01-12 KR KR1020017008693A patent/KR100611265B1/ko active IP Right Grant
- 2000-01-12 WO PCT/JP2000/000110 patent/WO2000042062A1/ja active IP Right Grant
- 2000-01-12 AT AT00900351T patent/ATE331730T1/de active
- 2000-01-12 DK DK00900351T patent/DK1142905T3/da active
- 2000-01-12 CN CNB00802510XA patent/CN1173990C/zh not_active Expired - Lifetime
- 2000-01-12 ES ES00900351T patent/ES2265906T3/es not_active Expired - Lifetime
- 2000-01-12 JP JP2000593629A patent/JP3554707B2/ja not_active Expired - Lifetime
-
2003
- 2003-10-15 US US10/684,656 patent/US7098024B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20040082054A1 (en) | 2004-04-29 |
CN1335852A (zh) | 2002-02-13 |
CA2356845C (en) | 2010-10-19 |
PT1142905E (pt) | 2006-10-31 |
DK1142905T3 (da) | 2006-09-18 |
US7098024B2 (en) | 2006-08-29 |
ATE331730T1 (de) | 2006-07-15 |
KR100611265B1 (ko) | 2006-08-10 |
JP3554707B2 (ja) | 2004-08-18 |
EP1142905A4 (en) | 2004-05-19 |
CA2356845A1 (en) | 2000-07-20 |
EP1142905B1 (en) | 2006-06-28 |
CN1173990C (zh) | 2004-11-03 |
EP1142905A1 (en) | 2001-10-10 |
DE60029084T2 (de) | 2007-02-01 |
AU2002700A (en) | 2000-08-01 |
WO2000042062A1 (fr) | 2000-07-20 |
ES2265906T3 (es) | 2007-03-01 |
DE60029084D1 (de) | 2006-08-10 |
US6670326B1 (en) | 2003-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5907931B2 (ja) | チアクマイシン生産 | |
KR100611265B1 (ko) | 신규 뎁시펩티드 화합물 | |
JP4521145B2 (ja) | 抗生物質カプラザマイシン類およびその製造法 | |
US5468849A (en) | Rebeccamycin analogs by tryptophan analogs feeding | |
US7098186B2 (en) | Depsipeptide compound | |
RU2228337C2 (ru) | Ванкорезмицин (варианты), его использование, штамм amycolatopsis вида hil-006734 для его получения | |
US5147860A (en) | Tan-1120, its derivatives, production and use thereof | |
JPH06128282A (ja) | 臭化物前駆物質物質供給によるレベカマイシン類似体 | |
US6004995A (en) | Macrolide compound 0406 | |
JPH04368388A (ja) | ダイネマイシンc抗腫瘍抗生物質 | |
JP4759756B2 (ja) | 抗生物質カプラザマイシンd、g、d1、g1とその製造法 | |
JPH07506332A (ja) | 医薬としての複素環化合物のリン酸エステル | |
JP3564566B2 (ja) | 新規rk−75物質、その製造方法及び用途 | |
JP2003210190A (ja) | 環状ペプチド化合物とその製造法 | |
CA2037783C (en) | Rebeccamycin analogs by tryptophan analogs feeding | |
JPH09301997A (ja) | 新規環状ペプチド系化合物 | |
JP2000086627A (ja) | 抗菌性物質be−54476及びその製造法 | |
JP2001011075A (ja) | 新規ジオキソピペラジン誘導体 | |
JPH03209384A (ja) | 新規な微生物変換生成物 | |
JP2006213703A (ja) | 新規発酵生産物 | |
JPH07278055A (ja) | 抗菌性物質be−40665類 | |
JP2001247571A (ja) | 縮合キノロン誘導体 | |
JPH03178988A (ja) | 生理活性物質tan―883、その製造法および用途 | |
JP2006213704A (ja) | 新規発酵生産物 | |
JPH02218684A (ja) | Y―09194l―b物質および該物質の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120724 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130719 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140721 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150716 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160630 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170719 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180718 Year of fee payment: 13 |